|Table of Contents|

The effect of polysaccharide on the STAT3 pathway associated biochemical markers was observed in the treatment of patients with nasopharyngeal carcinoma

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2018 05
Page:
685-690
Research Field:
Publishing date:

Info

Title:
The effect of polysaccharide on the STAT3 pathway associated biochemical markers was observed in the treatment of patients with nasopharyngeal carcinoma
Author(s):
Li Zhe1Liu Shujia1Chen Jinjie1Zhao Yi2Weng Yuling3
1.Dongguan Wanjiang Hospital,Guangdong Dongguan 523500,China;2.Guangdong Medical University,Guangdong Dongguan 523808,China;3.Dongguan People's Hospital,Guangdong Dongguan 523000,China.
Keywords:
ripe yellow polysaccharidenasopharyngeal carcinomaSTAT3 pathwayproinflammatory factor
PACS:
R739.63
DOI:
10.3969/j.issn.1672-4992.2018.05.009
Abstract:
Objective:To understand the specific effect of the patients on the STAT3 pathway of the statin and the related protein content.Methods:Were retrospectively analyzed from February 2015 to November,2016,132 patients with nasopharyngeal carcinoma.The control group with 66 patients underwent chemoradiation therapy,on the basis of control,the experimental group(66 cases) received the ehmannia glutinosa polysaccharide of the pills.Compare two groups of patients in early treatment,treatment for 15 days,30 days,60 days treatment with proinflammatory factor (TNF-α,IL-6,IL-1β,IL-8) and the STAT3 pathway related protein (NF-κB p65 protein,P-STAT3 protein) content differences.Results:At different time,the experimental group of TNF-α,IL-6,IL-1β,IL-8,NF-κB p65 protein and P-STAT3 proteins and the control group the TNF-α,IL-6,IL-8,NF-κB p65 protein and P-STAT3,had statistically significant differences.The difference of clinical therapeutic effect between the two groups was statistically significant(P<0.05),and the total relief and partial remission of patients in the experimental group were more than that of the control group.In 0 day,the proinflammatory factor and STAT3 pathway related protein content differences had no statistical significance (P>0.05),In 15th day,30th day,60th day,the content of proinflammatory factor differences were statistically significant (both P<0.05).The proinflammatory factor (TNF-α,IL-6,IL-1β,IL-8) and STAT3 pathway related protein (NF-κB p65 protein,P-STAT3 protein) content received repetitive measure analysis of variance,and their differences consisted of categories,time,category and the time of the interaction.Conclusion:Based on the concurrent chemoradiotherapy,patients with nasopharyngeal carcinoma gives rehmannia glutinosa polysaccharide the pills,STAT3 pathway in patients with nasopharyngeal carcinoma have a significant impact,so as to significantly improve the patient's body and proinflammatory factor related protein expression of specific amount.

References:

[1]Xu Shan,Li Wei,Zhao Ning,et al.MiRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3[J].Modern Oncology,2016,24(18):2866-2874.[许珊,李巍,赵宁,等.miRNA-124-3p通过靶向STAT3抑制鼻咽癌细胞生长和转移[J].现代肿瘤医学,2016,24(18):2866-2874.]
[2]Li Zhenhua,Li Cuiping,Zhang Xiangqiang,et al.EM-3 induced apoptosis and G2/M phase arrest and decreased the proportion of SP cells by Stat3 pathway[J].Chinese Journal of Biotechnology,2016,36(3):1-10.[李振华,李翠平,张相强,等.EM-3通过Stat3通路诱导鼻咽癌细胞凋亡和G2/M期阻滞并降低SP细胞比例[J].中国生物工程杂志,2016,36(3):1-10.]
[3]Hua Shengni,Xiao Lushan,Wu Dehua.HMGB1 on proliferation of human nasopharyngeal carcinoma cell line C666-1 in vitro[J].Journal of Southern Medical University,2015,35(11):1540-1545.[华胜妮,肖芦山,吴德华.HMGB1对人鼻咽癌细胞株C666-1体外增殖的影响[J].南方医科大学学报,2015,35(11):1540-1545.]
[4]Belton A,Xian L,Huso T,et al.STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)-STAT3 pathway[J].Leuk Lymphoma,2016,5:1-4.
[5]Han Lu.17-AAG on LMP1 expression and cell proliferation in EBV-positive tumor cells[D].Qingdao University,2015.[韩璐.17-AAG对EBV阳性肿瘤细胞LMP1表达及细胞增殖的影响[D].青岛大学,2015.]
[6]Li Qi,Liu Tongxin,Wang Rong,et al.C-Met inhibitor on the growth of human nasopharyngeal carcinoma cell line CNE-1[J].Journal of Practical Medicine,2015,31(4):536-539.[李琦,刘同欣,王融,等.c-Met抑制剂对人鼻咽癌细胞株CNE-1的生长抑制作用[J].实用医学杂志,2015,31(4):536-539.]
[7]Liu Yangyun,Liu Gengxun,Li Zhengxian,et al.STAT3 to predict the radiotherapy effect of nasopharyngeal carcinoma[J].Journal of Clinical Otorhinolaryngology Head and Neck Surgery,2014,28(18):1400-1402.[刘阳云,刘庚勋,李正贤,等.STAT3预测鼻咽癌放疗效应的价值[J].临床耳鼻咽喉头颈外科杂志,2014,28(18):1400-1402.]
[8]Wang Chunhua,Wang Sumei,Xu Tao,et al.The difference of Jab1 and Akt1 protein expression in nasopharyngeal carcinoma recurrence[J].Chinese Journal of Pathophysiology,2014,30(5):810-814.[王春华,王苏美,徐韬,等.鼻咽癌复发的分子标志物Jab1和Akt1蛋白表达的差异[J].中国病理生理杂志,2014,30(5):810-814.]
[9]Zhang Wei.STAT3,Cyclin D1 protein in EGCG-induced apoptosis of nasopharyngeal carcinoma cell line CNE-2 and its significance[D].Guilin Medical College,2014.[张伟.STAT3、Cyclin D1蛋白在EGCG促进鼻咽癌细胞CNE-2凋亡中的表达变化及意义[D].桂林医学院,2014.]
[10]Liu Yangyun,Liu Gengxun,Li Zhengxian,et al.STAT3 and VEGF in nasopharyngeal carcinoma and its significance[J].Journal of Clinical Military Medicine,2014,42(3):268-270.[刘阳云,刘庚勋,李正贤,等.STAT3与VEGF在鼻咽癌中的表达及意义[J].临床军医杂志,2014,42(3):268-270.]
[11]Li Caihong,Li Tao,Zhang Qunzhou,et al.Expression of angiogenesis-related factors in the differentiation of nasopharyngeal carcinoma stem cells and its effect on angiogenic cells[J].Acta Metallurgica Sinica,2013,40(7):629-634.[李彩虹,李涛,张群洲,等.鼻咽癌肿瘤干细胞分化过程中促血管生成相关因子的表达及其对血管生成细胞的影响[J].肿瘤防治研究,2013,40(7):629-634.]
[12]Ooft ML,Braunius WW,Heus P,et al.Prognostic significance of the EGFR pathway in nasopharyngeal carcinoma:a systematic review and meta-analysis[J].Biomark Med,2015,9(10):997-1010.
[13]Lin CH,Chao LK,Hung PH,et al.EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation[J].Int J Clin Exp Pathol,2014,7(5):2372-2381.
[14]Tan G,Tang X,Huang D,et al.Dinitrosopiperazine-mediated phosphorylated-proteins are involved in nasopharyngeal carcinoma metastasis[J].Int J Mol Sci,2014,15(11):54-71.
[15]Liao Qianjin.LPLUNC1 inhibits the activation of NF-κB and Stat3 signaling pathway in the development of nasopharyngeal carcinoma promoted by proinflammatory cytokines IL-6[D].Central South University,2012.[廖前进.LPLUNC1抑制NF-κB和Stat3信号通路的激活抵抗促炎因子IL-6促进的鼻咽癌发生发展[D].中南大学,2012.]
[16]Yu Shengfu,Li Jin,Zhang Gongxiu.Effects of celecoxib and lovastatin on the expression of Caveolin-1 and the downstream signaling pathway in nasopharyngeal carcinoma cells[J].Western Medicine,2011,23(10):1859-1861.[余盛富,李谨,张功秀.塞来昔布和洛伐他汀对鼻咽癌细胞Caveolin-1的表达及下游信号通路的影响[J].西部医学,2011,23(10):1859-1861.]
[17]Wu Minhua,Chen Xiaoyi,Chen Dong.Expression of transcriptional activator factor 3 and latent membrane protein 1 in nasopharyngeal carcinoma and its relationship[J].Journal of Xi'an Jiaotong University (Medical Sciences),2010,31(5):634-636,639.[吴民华,陈小毅,陈东.鼻咽癌组织中信号转导与转录活化因子3与潜伏膜蛋白1的表达及其关系[J].西安交通大学学报(医学版),2010,31(5):634-636,639.]
[18]Wang Yanping,Meng Dawei,Bao Jimin,et al.Effects of gefitinib combined with paclitaxel on phosphorylation of EGFR and STAT3 proteins in nasopharyngeal carcinoma HNE1 cells[J].Journal of Shandong Medicine,2010,50(23):46-47.[王艳萍,孟大为,暴继敏,等.吉非替尼联合紫杉醇对鼻咽癌HNE1细胞EGFR、STAT3蛋白磷酸化的影响及意义[J].山东医药,2010,50(23):46-47.]
[19]Yuan Qi.LMP1 regulates transcription factor EGFR and STAT3 in nasopharyngeal carcinoma cell nuclear interactions[D].Central South University,2010.[袁琦.LMP1调控转录因子EGFR和STAT3在鼻咽癌细胞核相互作用的研究[D].中南大学,2010.]

Memo

Memo:
广东省中医药局科研基金项目(编号:2162164);广东省自然科学基金项目(编号:2015A030310046)
Last Update: 1900-01-01